Qingping Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qingping Yao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Kenneth J. Tomecki
Dermatology, Cleveland Clinic, Cleveland, OH
4 shared publicationsLan Zhou
Department of Neurology, Cleveland Clinic, Cleveland, Ohio
2 shared publicationsRoy D. Altman
David Geffen Medical School at UCLA
2 shared publicationsXiaofeng Wang
2 shared publicationsAaron Hoschar
1 shared publicationB. Shen
Department of Rheumatic and Immunologic Diseases, Department of Anatomic Pathology, Department of Gastroenterology/Hepatology and Department of Pathobiology, Cleveland Clinic, Cleveland, OH, USA
1 shared publication
Latest Publications
- 1 December 2015
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 45 (3) , 357-360
Granulomatous disease associated with NOD2 sequence variants and familial camptodactyly: An intermediate form of NOD2-associated diseases?
- 1 December 2015
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 45 (3) , 357-360
Granulomatous disease associated with NOD2 sequence variants and familial camptodactyly: An intermediate form of NOD2-associated diseases?
- 26 June 2015
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 17 (8) , 1-6
RS3PE: Clinical and Research Development
Remitting seronegative symmetrical synovitis with pitting edema or RS3PE is a rare elderly-onset rheumatic syndrome. Although there are overlapping clinical manifestations between RS3PE, elderly-onset rheumatoid arthritis, and polymyalgia rheumatica, RS3PE has distinct characteristics. RS3PE can be associated with neoplasia and various rheumatic conditions, suggesting that it may be heterogeneous, and is considered as a paraneoplastic rheumatic disease. The pathogenesis of RS3PE may involve vascular endothelial growth factor and infection in RS3PE based upon limited data. Patients with RS3PE without concomitant malignancy respond well to small doses of glucocorticoids and carry good prognosis.
- 26 June 2015
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 17 (8) , 1-6
RS3PE: Clinical and Research Development
Remitting seronegative symmetrical synovitis with pitting edema or RS3PE is a rare elderly-onset rheumatic syndrome. Although there are overlapping clinical manifestations between RS3PE, elderly-onset rheumatoid arthritis, and polymyalgia rheumatica, RS3PE has distinct characteristics. RS3PE can be associated with neoplasia and various rheumatic conditions, suggesting that it may be heterogeneous, and is considered as a paraneoplastic rheumatic disease. The pathogenesis of RS3PE may involve vascular endothelial growth factor and infection in RS3PE based upon limited data. Patients with RS3PE without concomitant malignancy respond well to small doses of glucocorticoids and carry good prognosis.
- Open Access
- 19 November 2013
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (5) , 958-960
NOD2-associated autoinflammatory disease: an exploratory study of its pathogenesis
S ir , We previously reported an autoinflammatory disease associated with nucleotide-binding oligomerization domain containing protein 2 ( NOD2 ) gene mutations, designated as NOD2 -associated autoinflammatory disease (NAID) [ 1 , 2 ]. To date, none of the studies of NOD2 mutations have demonstrated spontaneous inflammation in NOD2 -associated diseases [ 3 ]. Herein we report a patient with NAID to illustrate the pathogenic role of NOD2 mutations and explore the pathogenesis of the disease.
- 19 November 2013
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (5) , 958-960
Open AccessNOD2-associated autoinflammatory disease: an exploratory study of its pathogenesis
S ir , We previously reported an autoinflammatory disease associated with nucleotide-binding oligomerization domain containing protein 2 ( NOD2 ) gene mutations, designated as NOD2 -associated autoinflammatory disease (NAID) [ 1 , 2 ]. To date, none of the studies of NOD2 mutations have demonstrated spontaneous inflammation in NOD2 -associated diseases [ 3 ]. Herein we report a patient with NAID to illustrate the pathogenic role of NOD2 mutations and explore the pathogenesis of the disease.
- 1 October 2013
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (10) , 1768-1769
Ocular Myositis Occurring with NOD2-associated Autoinflammatory Disease
- 1 October 2013
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (10) , 1768-1769
Ocular Myositis Occurring with NOD2-associated Autoinflammatory Disease
- 1 August 2013
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 43 (1) , 125-130
Nucleotide-binding oligomerization domain containing 2: Structure, function, and diseases
- 1 August 2013
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 43 (1) , 125-130
Nucleotide-binding oligomerization domain containing 2: Structure, function, and diseases
- Open Access
- 12 April 2013
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 52 (11) , 2095-2097
Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease
Sir, We previously reported an autoinflammatory disease associated with nucleotide-binding oligomerization domain containing protein 2 (NOD2) gene mutations, designated as NOD2-associated autoinflammatory disease (NAID) [1, 2]. Herein we report the presence of distal lower extremity (ankle and foot) swelling as a prominent phenotype of this disease.
- 12 April 2013
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 52 (11) , 2095-2097
Open AccessDistal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease
Sir, We previously reported an autoinflammatory disease associated with nucleotide-binding oligomerization domain containing protein 2 (NOD2) gene mutations, designated as NOD2-associated autoinflammatory disease (NAID) [1, 2]. Herein we report the presence of distal lower extremity (ankle and foot) swelling as a prominent phenotype of this disease.
- 1 April 2013
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 68 (4) , 624-631
Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations
- 1 April 2013
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 68 (4) , 624-631
Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations
- 7 February 2013
- Vol. 31 (2) , 289-94
IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome: a Caucasian patient and literature review.
This paper aims to report a case of IgG4-related Mikulicz's disease with a systematic review. The relevant English literature was searched using the keywords 'Mikulicz's disease' and 'IgG4'. Original and review articles were reviewed, and the clinical scenarios were exemplified with a case report. A 49-year-old Caucasian man presented with axillary lymphadenopathy and bilateral parotid/submandibular enlargement. A chest computerized tomography showed mediastinal lymphadenopathy, with low metabolic activity on the position emission tomography. A histopathological study showed an IgG4/IgG ratio of 75% in the plasma cells of the submandibular glands, associated with high levels of total serum IgG and IgG4. He had dry mouth, but minor salivary gland biopsy was negative without xerophthalmia. He had nasal obstruction and dyspnea, notably with supine position/cervical rotation, which substantially improved with glucocorticoid treatment. He had newly diagnosed diabetes mellitus with hyperlipasaemia and diffuse pancreatic swelling supportive of autoimmune pancreatitis. Our case report supports the literature that there are similarities between IgG4-related Mikulicz's disease and Sjögren's syndrome, but the differences are significant. IgG4-related Mikulicz's disease is a multi-organ lymphoproliferative disease distinct from Sjögren's syndrome.
- 7 February 2013
- Vol. 31 (2) , 289-94
IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome: a Caucasian patient and literature review.
This paper aims to report a case of IgG4-related Mikulicz's disease with a systematic review. The relevant English literature was searched using the keywords 'Mikulicz's disease' and 'IgG4'. Original and review articles were reviewed, and the clinical scenarios were exemplified with a case report. A 49-year-old Caucasian man presented with axillary lymphadenopathy and bilateral parotid/submandibular enlargement. A chest computerized tomography showed mediastinal lymphadenopathy, with low metabolic activity on the position emission tomography. A histopathological study showed an IgG4/IgG ratio of 75% in the plasma cells of the submandibular glands, associated with high levels of total serum IgG and IgG4. He had dry mouth, but minor salivary gland biopsy was negative without xerophthalmia. He had nasal obstruction and dyspnea, notably with supine position/cervical rotation, which substantially improved with glucocorticoid treatment. He had newly diagnosed diabetes mellitus with hyperlipasaemia and diffuse pancreatic swelling supportive of autoimmune pancreatitis. Our case report supports the literature that there are similarities between IgG4-related Mikulicz's disease and Sjögren's syndrome, but the differences are significant. IgG4-related Mikulicz's disease is a multi-organ lymphoproliferative disease distinct from Sjögren's syndrome.
- 28 November 2012
- Vol. 31 (1) , 156
Thiopurine methyltransferase measurement may not predict azathiopurine-associated non-myelotoxicity.
- 28 November 2012
- Vol. 31 (1) , 156
Thiopurine methyltransferase measurement may not predict azathiopurine-associated non-myelotoxicity.
- 22 August 2012
- Vol. 5 (4) , 316-20
The clinical utility of anti-chromatin antibodies as measured by BioPlex 2200 in the diagnosis of systemic lupus erythematosus versus other rheumatic diseases.
The detection of autoantibodies is indispensable to systemic lupus erythematosus (SLE). Bioplex 2200 ANA screen is a multiplex immunoassay system that allows simultaneous determination of autoantibodies to extractable nuclear antigens (ENA) including anti-chromatin antibodies (ACAs). However, the clinical significance of the ACAs by this new method in SLE patients has not been studied in comparison with other rheumatic disorders. We performed a retrospective study of patients with rheumatic diseases to assess the diagnostic value of the ACAs by Bioplex 2200 method in SLE. Adult patients with rheumatic complaints seen by rheumatologists at the Cleveland Clinic between January 2008 and February 2010 were screened for positive anti-ENA antibodies by the Bioplex 2200. Patients with positive anti-ENA antibodies were classified into two populations based upon the presence and absence of the ACAs. We retrospectively studied the clinical and laboratory data of these patients. A total of 764 subjects with positive anti-ENA antibodies were screened, including 115 with positive ACAs. There were 93 SLE patients consisting of 58 with positive ACAs and 35 with negative ACAs. The sensitivity, specificity, positive predictive value and negative predictive value of the ACAs in SLE were 62.4%, 91.5%, 50.4% and 94.6% respectively. Apart from SLE, positive ACAs were associated with mixed connective tissue disease (MCTD)/undifferentiated CTD (UCTD) and other autoimmune diseases. No correlation was found between the ACAs and lupus glomerulonephritis or anti-dsDNA antibodies. Measurement of the ACAs by the Bioplex 2200 is specific for diagnosing SLE but not useful for differentiating between SLE and MCTD/UCTD.
- 22 August 2012
- Vol. 5 (4) , 316-20
The clinical utility of anti-chromatin antibodies as measured by BioPlex 2200 in the diagnosis of systemic lupus erythematosus versus other rheumatic diseases.
The detection of autoantibodies is indispensable to systemic lupus erythematosus (SLE). Bioplex 2200 ANA screen is a multiplex immunoassay system that allows simultaneous determination of autoantibodies to extractable nuclear antigens (ENA) including anti-chromatin antibodies (ACAs). However, the clinical significance of the ACAs by this new method in SLE patients has not been studied in comparison with other rheumatic disorders. We performed a retrospective study of patients with rheumatic diseases to assess the diagnostic value of the ACAs by Bioplex 2200 method in SLE. Adult patients with rheumatic complaints seen by rheumatologists at the Cleveland Clinic between January 2008 and February 2010 were screened for positive anti-ENA antibodies by the Bioplex 2200. Patients with positive anti-ENA antibodies were classified into two populations based upon the presence and absence of the ACAs. We retrospectively studied the clinical and laboratory data of these patients. A total of 764 subjects with positive anti-ENA antibodies were screened, including 115 with positive ACAs. There were 93 SLE patients consisting of 58 with positive ACAs and 35 with negative ACAs. The sensitivity, specificity, positive predictive value and negative predictive value of the ACAs in SLE were 62.4%, 91.5%, 50.4% and 94.6% respectively. Apart from SLE, positive ACAs were associated with mixed connective tissue disease (MCTD)/undifferentiated CTD (UCTD) and other autoimmune diseases. No correlation was found between the ACAs and lupus glomerulonephritis or anti-dsDNA antibodies. Measurement of the ACAs by the Bioplex 2200 is specific for diagnosing SLE but not useful for differentiating between SLE and MCTD/UCTD.